Clinical Trial Update: Efficacy, Safety, and Acceptability of Mifepristone 50 mg Once-weekly as a Contraceptive [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating efficacy, safety, and acceptability of weekly 50 mg mifepristone as a female contraception option.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Female Contraception

Drugs mentioned

• Mifepristone (mifepristone)

Snippet

Sponsor: Leiden University Medical Center | Conditions: Female Contraception | Phase 3 | Status: ACTIVE_NOT_RECRUITING